カテゴリ： MarketLine, イスラエル, 企業調査

Enzymotec Ltd：企業の戦略・SWOT・財務情報

◆英語タイトル：Enzymotec Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C4111
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：40
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イスラエル
◆産業分野：材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Enzymotec Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Enzymotec Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Enzymotec Ltd (Enzymotec), a subsidiary of Frutarom Industries Ltd., produces, and markets of nutritional ingredients and medical foods for the entire human life-cycle such as from infancy to old age. The company develops clinically-validated products including bio-functional, lipid-based compounds compounds which meet a wide range of consumer demands on optimal development, supplementation for nutritional deficiencies and needs, and the management of medical disorders and diseases. Its major products include Infat, EnzyPS Solutions, Vayacog, Vayarin, Vayarol, NoctoPlex, LuciPlex, NoctoPlex for kids, and Addivance for kids. The company market products under Vayacog,INFAT,Vayarin, SHARP PS, SHARP PS GREEN,NOCTOPLEX, NOCTOPLEX for Kids, and LUCIPLEX brand names. The company has business presence in India, the US, China, and Sweden. Enzymotec is headquartered in Migdal HaEmek, Israel.

Scope

- Detailed information on Enzymotec Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Enzymotec Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Enzymotec Ltd including a breakdown and examination of key business segments
- Intelligence on Enzymotec Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Enzymotec Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Enzymotec Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Enzymotec Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Enzymotec Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Enzymotec Ltd: Company Overview 8
Enzymotec Ltd: Overview and Key Facts 8
Enzymotec Ltd: Overview 8
Enzymotec Ltd: Key Facts 8
Enzymotec Ltd: Key Employees 9
Enzymotec Ltd: Key Employee Biographies 10
Enzymotec Ltd: Major Products and Services 11
Enzymotec Ltd: Company History 12
Enzymotec Ltd: Management Statement 14
Enzymotec Ltd: Locations and Subsidiaries 15
Enzymotec Ltd: Key Competitors 16
Enzymotec Ltd: Company Analysis 17
Enzymotec Ltd: Business Description 17
Enzymotec Ltd: SWOT Analysis 18
Enzymotec Ltd: SWOT Overview 18
Enzymotec Ltd: Strengths 18
Enzymotec Ltd: Weaknesses 19
Enzymotec Ltd: Opportunities 19
Enzymotec Ltd: Threats 20
Enzymotec Ltd: Corporate Financial Deals Activity 22
Enzymotec Ltd: Financial Deals Overview 22
Enzymotec Ltd: Targets and Partners 24
Enzymotec Ltd: Top Deals 2014 – 2018YTD* 25
Enzymotec Ltd: Advisors 26
Enzymotec Ltd: Top Legal Advisors 26
Enzymotec Ltd: Top Financial Advisors 26
Enzymotec Ltd: Mergers and Acquisitions 27
Enzymotec Ltd: Capital Raising 28
Enzymotec Ltd: Partnership 29
Enzymotec Ltd: Private Equity and Ownership 30
Enzymotec Ltd: Recent Developments 31
Enzymotec Ltd: News and Events Summary 31
Enzymotec Ltd: Business Expansion 33
Enzymotec Ltd: Contracts 34
Enzymotec Ltd: Corporate Governance 35
Enzymotec Ltd: Financial Performance 36
Enzymotec Ltd: Strategy and Operations 36
Appendix 38
Contact Us 38
Methodology 38
About MarketLine 39

List of Tables
Table 1: Enzymotec Ltd: Key Facts
Table 2: Enzymotec Ltd: Key Employees
Table 3: Enzymotec Ltd: Locations and Subsidiaries
Table 4: Enzymotec Ltd: Key Competitors
Table 5: Enzymotec Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Enzymotec Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Enzymotec Ltd: M&A Average Deal Size - Value (US$m)
Table 8: Enzymotec Ltd: Targets and Partners
Table 9: Enzymotec Ltd: Top Deals 2014 - 2018YTD*
Table 10: Enzymotec Ltd: Legal Advisor Ranking by Value (US$m)
Table 11: Enzymotec Ltd: Financial Advisor Ranking by Value (US$m)
Table 12: Enzymotec Ltd: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Enzymotec Ltd: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 14: Enzymotec Ltd: Capital Raising by Deal Type (2014 - YTD*2018)
Table 15: Enzymotec Ltd: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 16: Enzymotec Ltd: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 17: Enzymotec Ltd: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 18: Enzymotec Ltd: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 19: Enzymotec Ltd: News and Events Summary
Table 20: Enzymotec Ltd: Business Expansion
Table 21: Enzymotec Ltd: Contracts
Table 22: Enzymotec Ltd: Corporate Governance
Table 23: Enzymotec Ltd: Financial Performance
Table 24: Enzymotec Ltd: Strategy and Operations

List of Figures
Figure 1: Enzymotec Ltd: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Enzymotec Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Enzymotec Ltd: M&A Average Deal Size - Value (US$m)
Figure 4: Enzymotec Ltd: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Enzymotec Ltd: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 6: Enzymotec Ltd: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 7: Enzymotec Ltd: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 8: Enzymotec Ltd: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 9: Enzymotec Ltd: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 10: Enzymotec Ltd: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Enzymotec Ltd：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Ingredion Incorporated：企業の戦略・SWOT・財務情報
    Ingredion Incorporated - Strategy, SWOT and Corporate Finance Report Summary Ingredion Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Clalit Health Services：企業の戦略的SWOT分析
    Clalit Health Services - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Naspers Limited：企業の戦略・SWOT・財務情報
    Naspers Limited - Strategy, SWOT and Corporate Finance Report Summary Naspers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Guided Therapeutics Inc (GTHP)-医療機器分野：企業M&A・提携分析
    Summary Guided Therapeutics Inc (GTI), formerly SpectRx Inc is a biotechnology company that offers platform technology for the early detection of disease that leads to cancer. The company provides products for the non-invasive cervical cancer detection markets. Its products include luviva advanced c …
  • Octapharma AG：企業の戦略・SWOT・財務情報
    Octapharma AG - Strategy, SWOT and Corporate Finance Report Summary Octapharma AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Coca-Cola FEMSA SAB de CV：企業の戦略・SWOT・財務情報
    Coca-Cola FEMSA SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola FEMSA SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Beijing SL Pharmaceutical Co Ltd (002038)-製薬・医療分野：企業M&A・提携分析
    Summary Beijing SL Pharmaceutical Co Ltd (SL Pharma), formerly Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd is a bio-pharmaceutical company that develops and markets gene engineering drugs. The company offers products in the field of oncology, organ transplantation, wound management, cardivascular, …
  • Silver Bull Resources, Inc.：企業の戦略・SWOT・財務分析
    Silver Bull Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary Silver Bull Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Xiwang Sugar Holdings Co Limited：企業の戦略・SWOT・財務情報
    Xiwang Sugar Holdings Co Limited - Strategy, SWOT and Corporate Finance Report Summary Xiwang Sugar Holdings Co Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • The Toronto-Dominion Bank：企業の戦略・SWOT・財務分析
    The Toronto-Dominion Bank - Strategy, SWOT and Corporate Finance Report Summary The Toronto-Dominion Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • PacifiCorp：企業の発電所・SWOT分析2018
    PacifiCorp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executi …
  • PT. Indonesia Power：企業の戦略的SWOT分析
    PT. Indonesia Power - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • E.ON SE：発電所・企業SWOT分析
    E.ON SE - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives …
  • Seminole Electric Cooperative, Inc.：発電所・企業SWOT分析
    Seminole Electric Cooperative, Inc. – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Bank Hapoalim Private Banking：企業の戦略・SWOT・財務情報
    Bank Hapoalim Private Banking - Strategy, SWOT and Corporate Finance Report Summary Bank Hapoalim Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Tsumura & co (4540)：製薬・医療：M&Aディール及び事業提携情報
    Summary Tsumura & co (Tsumura) is a traditional pharmaceutical products company, which undertakes the manufacturing and sale of Kampo extract intermediates and granular Kampo formulations. Its product portfolio includes a range of prescription Kampo products, other pharmaceuticals, over-the-counter …
  • Oasis Petroleum Inc (OAS)：企業の財務・戦略的SWOT分析
    Oasis Petroleum Inc (OAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Catalyst Biosciences Inc (CBIO)：企業の財務・戦略的SWOT分析
    Summary Catalyst Biosciences Inc (Catalyst Biosciences) is a clinical-stage biopharmaceutical company that develops protease-based advanced medicines to treat hematological indications. The company specializes in hemostasis, with focus on subcutaneous prophylaxis of hemophilia and surgery, and anti- …
  • Ameresco Inc (AMRC)：企業の財務・戦略的SWOT分析
    Ameresco Inc (AMRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Rockwell Automation Inc (ROK)：石油・ガス：M&Aディール及び事業提携情報
    Summary Rockwell Automation Inc (Rockwell) is a provider of industrial automation power, control and information systems. The company offers connected components, midrange architecture system, asset and consultancy management; engineered packages and panels integration; front end engineering and des …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆